second-line systemic therapy

DRUG2 trials

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University, Sun Yat-sen University

Conditions

Hepatocellular CarcinomaMetastatic Non-Small Cell Lung CancerNSCLC Stage IVOligoProgressive Metastatic DiseaseOligoprogression

Phase 2

Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment

Not yet recruitingNCT06592612

Sun Yat-sen UniversityHepatocellular Carcinoma, Oligoprogression

Start: 2024-10-01End: 2026-10-31Target: 70Updated: 2024-09-19

Phase 3

Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer

RecruitingNCT06523673

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityMetastatic Non-Small Cell Lung Cancer, NSCLC Stage IV, OligoProgressive Metastatic Disease

Start: 2024-09-30End: 2027-09-30Target: 104Updated: 2024-08-30